Below are the most recent publications written about "Thiazoles" by people in Profiles.
-
Zhu HT, Luo J, Peng Y, Cheng XF, Wu SZ, Zhao YD, Chang L, Sun ZJ, Dong DL. Nitazoxanide protects against experimental ulcerative colitis through improving intestinal barrier and inhibiting inflammation. Chem Biol Interact. 2024 May 25; 395:111013.
-
Lu W, Huang J, Flores J, Li P, Wang W, Liu S, Zhang JH, Tang J. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR?/d/CD300a/SHP1 pathway after GMH in neonatal rats. Exp Neurol. 2024 02; 372:114615.
-
Almanasra A, Havranek B, Islam SM. In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize ?-hexosaminidase A causing Tay-Sachs disease. Proteins. 2021 11; 89(11):1587-1601.
-
Gamdzyk M, Doycheva DM, Kang R, Tang H, Travis ZD, Tang J, Zhang JH. GW0742 activates miR-17-5p and inhibits TXNIP/NLRP3-mediated inflammation after hypoxic-ischaemic injury in rats and in PC12 cells. J Cell Mol Med. 2020 11; 24(21):12318-12330.
-
Dahiya R, Dahiya S, Fuloria NK, Kumar S, Mourya R, Chennupati SV, Jankie S, Gautam H, Singh S, Karan SK, Maharaj S, Fuloria S, Shrivastava J, Agarwal A, Singh S, Kishor A, Jadon G, Sharma A. Natural Bioactive Thiazole-Based Peptides from Marine Resources: Structural and Pharmacological Aspects. Mar Drugs. 2020 Jun 24; 18(6).
-
Kaoud TS, Johnson WH, Ebelt ND, Piserchio A, Zamora-Olivares D, Van Ravenstein SX, Pridgen JR, Edupuganti R, Sammons R, Cano M, Warthaka M, Harger M, Tavares CDJ, Park J, Radwan MF, Ren P, Anslyn EV, Tsai KY, Ghose R, Dalby KN. Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo. Nat Commun. 2019 11 19; 10(1):5232.
-
Lee SR, Choi EK, Han KD, Jung JH, Oh S, Lip GYH. Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation. Sci Rep. 2019 04 30; 9(1):6690.
-
Perelygina L, Buchbinder D, Dorsey MJ, Eloit M, Hauck F, Hautala T, Moshous D, Uriarte I, Deripapa E, Icenogle J, Sullivan KE. Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma. J Clin Immunol. 2019 01; 39(1):112-117.
-
Shpak M, Ramakrishnan A, Nadasdy Z, Cowperthwaite M, Fanale C. Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants. Stroke. 2018 12; 49(12):2851-2856.
-
Rowland LK, Campbell PS, Mavingire N, Wooten JV, McLean L, Zylstra D, Thorne G, Daly D, Boyle K, Whang S, Unternaehrer J, Brantley EJ. Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death. J Cell Biochem. 2019 04; 120(4):6004-6014.